© 2020 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
All News
The relationship of parental eating behaviors and their children and adolescents’ weight
November 23, 2020
Encourage parents to model healthful eating behaviors and positive relationships with good eating habits.
In case you missed it: November 9 to November 13
November 13, 2020
It was a very busy week for the Contemporary Pediatrics team.
Meet the Board: Andrew J Schuman, MD, FAAP
November 06, 2020
Contemporary Pediatrics sat down with Andrew J. Schuman, MD, FAAP, who is a clinical assistant professor of pediatrics at the Geisel School of Medicine at Dartmouth and also a practicing pediatrician, to talk about why he went into medicine and what he loves about pediatrics.
New drugs for children in 2019-2020
November 06, 2020
The impact of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act continues to benefit children’s health.
Incidence of SUDC likely higher than previously thought
November 05, 2020
Sudden unexplained death in childhood (SUDC) is a leading category of death for toddlers, but a new report indicates that we may be underestimating the incidence of SUDC.
Kindergarten readiness has long-reaching education and health outcomes
November 04, 2020
School readiness has long been touted as a way to ensure the best educational outcomes, but a new study indicates that it can also help with health outcomes too.
What's new on Contemporary Pediatrics: November 2 to November 6
November 02, 2020
A look at what to expect from Contemporary Pediatrics this week
In case you missed it: October 26 to October 30
October 30, 2020
It was a very busy week for the Contemporary Pediatrics team.
Can isotonic fluid therapy lead to electrolyte disorders in acutely ill kids?
October 30, 2020
Recent guidelines recommend using commercially available plasmalike isotonic fluid therapy, but could this have a negative impact on acutely ill children.
FDA approves Sklice for OTC use
October 28, 2020
Sklice (ivermectin) lotion, 0.5% has been approved for over-the-counter (OTC) use by the US Food and Drug Administration (FDA) in children aged 6 months and older.